skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Plasma clearance of human extracellular-superoxide dismutase C in rabbits

Journal Article · · J. Clin. Invest.; (United States)
DOI:https://doi.org/10.1172/JCI113676· OSTI ID:6703011

Extracellular-superoxide dismutase (EC-SOD) is heterogenous in the vasculature with regard to heparin affinity and can be separated into three fractions: A, without affinity; B, with weak affinity; and C, with relatively strong heparin affinity. The plasma clearance of intravenously injected 125I-labeled and unlabeled human EC-SOD C was studied in rabbits. About 90% of injected 125I-EC-SOD C was eliminated from the blood within 5-10 min. Injection of heparin after 10 or 20 min led to an immediate release of all sequestered 125I-EC-SOD C back to the blood plasma. Later injections of heparin led to diminished release, although release could still be demonstrated after 72 h. A half-time of approximately 10 h could be calculated for heparin-releasable 125I-EC-SOD C. Unlabeled EC-SOD C, determined as enzymic activity and with ELISA, was likewise sequestered and released to the same degree as 125I-labeled EC-SOD C by heparin as tested at 20 min and 5 h. The immediacy of the heparin-induced release indicates that the sequestered enzyme had been bound to endothelial cell surfaces. The length of the half-time suggests that the putative cell surface binding has a physiological function and is not primarily a step in enzyme degradation. The distribution of sequestered 125I-labeled EC-SOD C to different organs was determined at times between 10 min and 24 h. Of the organs, the liver contained the most 125I-EC-SOD C, followed by kidney, spleen, heart, and lung. At all investigated times, the content in the analyzed organs was nearly as large as the amount that could be promptly released to plasma by intravenous heparin. This indicates that almost all 125I-EC-SOD C in the organs was present on endothelial cell surfaces and was not bound by other tissue cell surfaces, or was present within the cells.

Research Organization:
Umea University Hospital (Sweden)
OSTI ID:
6703011
Journal Information:
J. Clin. Invest.; (United States), Vol. 82:3
Country of Publication:
United States
Language:
English

Similar Records

Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells
Journal Article · Mon Dec 05 00:00:00 EST 1988 · J. Biol. Chem.; (United States) · OSTI ID:6703011

Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat
Journal Article · Wed Feb 01 00:00:00 EST 1989 · Circ. Res.; (United States) · OSTI ID:6703011

Metabolic fate of rat heart endothelial lipoprotein lipase
Journal Article · Thu Sep 01 00:00:00 EDT 1988 · Am. J. Physiol.; (United States) · OSTI ID:6703011